About Henry Plain, Jr.
Form D filings for Nuvaira from 2012 to 2024 list Henry Plain, Jr. as director.
Form D filings also name Henry Plain, Jr. as a director at Earlens and Moximed.
Henry Plain, Jr. first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Henry Plain, Jr. in the role, so the role may have started earlier or lasted longer.
Nuvaira, Inc.
Director
2012 – 2024 · Minneapolis, MN
Develops a lung treatment device for people with chronic obstructive pulmonary disease.
Key Colleagues at Startups
The people Henry Plain, Jr. works with at each company, as listed on that company's latest Form D.
Nuvaira, Inc. · Form D, May 9, 2024
JR
Jonathan Root
Director
TH
Timothy Herbert
Director

Dennis Wahr
President & CEO, director
DM
David Van Meter
Director
JE
Jaques Essinger
Director
TG
Tom Griffin
Executive officer
MC
Michael Carusi
Director
Earlens Corp · Form D, May 24, 2018
PL
Phil Lyons
Executive officer
JB
Judy Brimacombe
Executive officer
WF
William Facteau
President and CEO, director
YL
Yoh-Chie Lu
Director
TP
Thomas Prescott
Director
AT
Art Taylor
Director
MB
Mark Bishop
Executive officer
FT
Frank Torti
Director
GK
Greg Koskowich
Executive officer
RC
Robert Croce
Director
BS
Bernard Shay
Executive officer
SE
Steven Elms
Director
RD
Rodney Perkins, M.D.
Director
JJ
Jeff Jones
Executive officer
Moximed, Inc · Form D, Mar 31, 2017
AF
Arthur Franken
Director
RA
Robert Anderson
Director
DM
Dan Murray
Chief Financial Officer
RC
Robert Croce
Director
JM
Joshua Makower
Director
CS
Christopher Shen
Director
RD
Ryan Drant
Director
KS
Kevin Sidow
President/CEO and director